Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12262828 | 1.00 | CXCR1 (1.00) | CXCR1CXCR2 | |
| SCHEMBL12262801 | 1.00 | CXCR1 (1.00) | CXCR1CXCR2 | |
| SCHEMBL12262821 | 1.00 | CXCR1 (1.00) | CXCR1CXCR2 | |
| SCHEMBL12086644 | 0.90 | CXCR1 (1.00) | CXCR1CXCR2 | |
| SCHEMBL31065211 | 0.89 | CXCR1 (1.00) | CXCR1CXCR2 | |
| SCHEMBL12263764 | 0.89 | CXCR1 (1.00) | CXCR1CXCR2 | |
| SCHEMBL12262822 | 0.89 | CXCR1 (1.00) | CXCR1CXCR2 | |
| SCHEMBL12262837 | 0.89 | CXCR1 (1.00) | CXCR1CXCR2 | |
| SCHEMBL12086725 | 0.89 | CXCR2 (1.00) | CXCR1CXCR2 | |
| SCHEMBL12262982 | 0.89 | CXCR2 (0.79) | CXCR1CXCR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4686472-A1 | CXCL8 INHIBITORS FOR USE IN THE TREATMENT OF OCULAR GRAFT-VERSUS-HOST DISEASE | Dompé farmaceutici SpA (IT) | 2026-02-04 | — | — | EP | claimed |
| EP-4646193-A1 | CXCL8 INHIBITORS FOR USE IN THE TREATMENT OF OCULAR MUCOUS MEMBRANE PEMPHIGOID AND/OR ORAL MUCOUS MEMBRANE PEMPHIGOID | Dompé farmaceutici S.p.A. (IT) | 2025-11-12 | — | — | EP | claimed |
| WO-2024146918-A1 | CXCL8 INHIBITORS FOR USE IN THE TREATMENT OF OCULAR MUCOUS MEMBRANE PEMPHIGOID AND/OR ORAL MUCOUS MEMBRANE PEMPHIGOID | DOMPE' FARMACEUTICI SPA (IT) | 2024-07-11 | — | — | WO | claimed |
| EP-4301351-A1 | CXCL8 INHIBITOR AND PHARMACEUTICAL COMPOSITION THEREOF FOR USE IN THE TREATMENT OF SEIZURES | Dompe' Farmaceutici SpA (IT) | 2024-01-10 | — | — | EP | claimed |
| WO-2022184841-A1 | CXCL8 INHIBITOR AND PHARMACEUTICAL COMPOSITION THEREOF FOR USE IN THE TREATMENT OF SEIZURES | DOMPE' FARMACEUTICI SPA (IT) | 2022-09-09 | — | — | WO | claimed |
| EP-4646193-A1 | CXCL8 INHIBITORS FOR USE IN THE TREATMENT OF OCULAR MUCOUS MEMBRANE PEMPHIGOID AND/OR ORAL MUCOUS MEMBRANE PEMPHIGOID | Dompé farmaceutici S.p.A. (IT) | 2025-11-12 | — | — | EP | disclosed |
| EP-4563594-A1 | CXCL8 INHIBITORS FOR USE IN THE TREATMENT OF TUMORS WITH LOW STROMAL CAV1 LEVELS | Dompe' Farmaceutici SpA (IT) | 2025-06-04 | — | — | EP | disclosed |
| WO-2024146918-A1 | CXCL8 INHIBITORS FOR USE IN THE TREATMENT OF OCULAR MUCOUS MEMBRANE PEMPHIGOID AND/OR ORAL MUCOUS MEMBRANE PEMPHIGOID | DOMPE' FARMACEUTICI SPA (IT) | 2024-07-11 | — | — | WO | disclosed |
| EP-4301351-A1 | CXCL8 INHIBITOR AND PHARMACEUTICAL COMPOSITION THEREOF FOR USE IN THE TREATMENT OF SEIZURES | Dompe' Farmaceutici SpA (IT) | 2024-01-10 | — | — | EP | disclosed |
| WO-2022184841-A1 | CXCL8 INHIBITOR AND PHARMACEUTICAL COMPOSITION THEREOF FOR USE IN THE TREATMENT OF SEIZURES | DOMPE' FARMACEUTICI SPA (IT) | 2022-09-09 | — | — | WO | disclosed |